A bill to require the Federal Trade Commission to submit a report on foreign investment in the pharmaceutical industry of the United States, and for other purposes.
About This Bill
Committee
Latest Action · July 15, 2026
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.